Syncell December 2024 Series A Funding Round

Syncell, a company specializing in subcellular protein purification and spatial proteomics, announced the closure of a $15 million Series A funding round, led by Taiwania Capital with contributions from other investors. This brings the company’s total funding to $30 million. The funds will accelerate the global deployment of its Microscoop® platform, support commercial team expansion, and enhance operations.

Microscoop® facilitates high-precision protein analysis, aiding research in oncology, neurodegeneration, and drug discovery. Syncell also announced partnerships, including one with Thermo Fisher Scientific. The company will showcase its innovations at Cell Bio 2024.